Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial resistance.

NeoVolta is a developer of smart residential energy storage solutions.

VelosBio is an operator of a clinical-stage biopharmaceutical company intended to develop novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer. The company's ROR1-directed therapeutics is a cell-surface protein that is expressed on many hematologic and solid tumors but is absent from normal tissues, making it an attractive tumor-specific therapeutic target and has demonstrated positive preclinical results in tumor models, enabling institutions to get novel targeted therapies for use as monotherapy or in combination across a broad range of cancers. It was founded in 2017 and headquartered in San Diego, California.

Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial resistance.

VelosBio is an operator of a clinical-stage biopharmaceutical company intended to develop novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer. The company's ROR1-directed therapeutics is a cell-surface protein that is expressed on many hematologic and solid tumors but is absent from normal tissues, making it an attractive tumor-specific therapeutic target and has demonstrated positive preclinical results in tumor models, enabling institutions to get novel targeted therapies for use as monotherapy or in combination across a broad range of cancers. It was founded in 2017 and headquartered in San Diego, California.

DTx Pharma develops technology that will unleash RNA-based therapeutics as the modality of choice for personalized treatment across therapeutic areas. DTx Pharma believes its approach to delivering RNA medicines solves some of the issues that limited previous-generation platforms, including poor pharmacokinetics and insufficient cellular uptake.

TuSimple is a self-driving truck company developing a technology that allows driving from depot to depot without human intervention. The company's trucks are capable of self-driving from depot to depot and do so every day for its customers. It develops a commercial-ready Level 4 (SAE) fully autonomous driving solution for the logistics industry. The company is driven by a mission to increase safety, decrease transportation costs, and reduce carbon emissions. In 2015, Jianan Hao, Mo Chen, and Xiaodi Hou headquartered the company in San Diego, California.

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.

BioLegend is a biotechnology firm that offers immunological reagents for biomedical research.

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.

Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines.

BioLegend is a biotechnology firm that offers immunological reagents for biomedical research.

Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery.

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.

BioLegend is a biotechnology firm that offers immunological reagents for biomedical research.

TuSimple is a self-driving truck company developing a technology that allows driving from depot to depot without human intervention. The company's trucks are capable of self-driving from depot to depot and do so every day for its customers. It develops a commercial-ready Level 4 (SAE) fully autonomous driving solution for the logistics industry. The company is driven by a mission to increase safety, decrease transportation costs, and reduce carbon emissions. In 2015, Jianan Hao, Mo Chen, and Xiaodi Hou headquartered the company in San Diego, California.